Stoke Therapeutics, Inc. - COM (STOK)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
50 M
Holdings value Q1 2024
$676 M
Value change Q1 2024
+$114 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
97
Number of buys Q1 2024
63
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
86150R107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 50 M $676 M +$114 M $13.50 99
2023 Q4 41.7 M $219 M +$4.38 M $5.26 78
2023 Q3 43.9 M $173 M -$18.2 M $3.94 94
2023 Q2 46.5 M $494 M +$20.7 M $10.63 95
2023 Q1 44.6 M $372 M +$14.2 M $8.33 95
2022 Q4 39.5 M $365 M -$19.2 M $9.23 102
2022 Q3 38.1 M $489 M +$1.44 M $12.84 95
2022 Q2 37.9 M $501 M +$3.68 M $13.21 82
2022 Q1 38.8 M $817 M +$73 M $21.05 95
2021 Q4 35.4 M $848 M +$26.4 M $23.99 89
2021 Q3 19.3 M $491 M -$27.8 M $25.44 86
2021 Q2 20.2 M $680 M -$703 M $33.66 96
2021 Q1 38.4 M $1.49 B -$15.7 M $38.84 104
2020 Q4 38.4 M $2.38 B +$253 M $61.93 92
2020 Q3 34.6 M $1.16 B +$2.94 M $33.49 88
2020 Q2 34.9 M $824 M +$9.8 M $23.83 68
2020 Q1 34.6 M $791 M +$23.3 M $22.90 64
2019 Q4 33.5 M $948 M +$22.4 M $28.32 62
2019 Q3 15.9 M $339 M +$30.1 M $21.49 51
2019 Q2 14.2 M $408 M +$408 M $29.17 46